Tag Archives: Pfizer

STUDY: Viagra May Be Effective Against Alzheimer’s

Science Alert reports: Usage of the medication sildenafil – better known to most as the brand-name drug Viagra – is associated with dramatically reduced incidence of Alzheimer’s disease, new research suggests. According to a study led by researchers at the Cleveland Clinic, taking sildenafil is tied to a nearly 70 percent lower risk of developing Alzheimer’s compared to non-users. That’s …

Read More »

Pfizer Already Testing Its Vax Against Omicron Variant

The Daily Beast reports: Testing has already begun to determine whether the Pfizer vaccine protects against a mutant strain of COVID-19 that first appeared in Africa and has already made its way to East Asia and Europe, the Financial Times reported Friday. A spokesman for BioNTech noted that this line of the pandemic pathogen “differs significantly” from its predecessors due …

Read More »

FDA Approves Pfizer, Moderna Boosters For All Adults

The Washington Post reports: Federal regulators on Friday authorized Pfizer-BioNTech and Moderna coronavirus vaccine boosters for all adults, a one-size-fits-all strategy designed to shore up Americans’ defenses against a tenacious virus and reduce confusion over guidelines that have varied based on people’s age, occupation and where they live. The Food and Drug Administration cleared the boosters for people 18 and …

Read More »

US To Buy 10M Courses Of Pfizer COVID Pill In $5B Deal

Reuters reports: Pfizer Inc has signed a $5.29 billion deal with the U.S. government to deliver 10 million courses of its COVID-19 oral antiviral drug starting this year, the drugmaker said on Thursday. Pfizer on Tuesday filed for U.S. authorization of the drug, Paxlovid, and said it expects to manufacture 180,000 treatment courses by the end of next month and …

Read More »

Pfizer To Waive Overseas Royalties On Its COVID Pill

The Washington Post reports: Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population. In a statement issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based …

Read More »

Pfizer To Seek Approval For Booster For All Over 18

The Washington Post reports: Pfizer and its German partner BioNTech are expected to seek authorization for their coronavirus vaccine booster shot for anyone 18 and older, a move that could increase booster rates at a critical moment in the pandemic, according to three officials familiar with the situation. The request, which may be filed as soon as this week, is …

Read More »

Pfizer Says Its COVID Treatment Pill Is Highly Effective

CNBC reports: Pfizer said Friday that its easy-to-administer Covid-19 pill, used in combination with a widely used HIV drug, cut the risk of hospitalization or death by 89% in high-risk adults who’ve been exposed to the virus. It’s now the second antiviral pill behind Merck’s to demonstrate strong effectiveness for treating Covid at the first sign of illness. If cleared …

Read More »

CDC Grants Final Approval To Pfizer Vaccine For Kids

CNBC reports: Children ages 5 to 11 will be able to get a Covid-19 vaccine after the CDC cleared Pfizer’s doses for younger kids Tuesday night, allowing many parents across the U.S. to breathe a sigh of relief. CDC Director Dr. Rochelle Walensky, authorized the vaccine hours after a unanimous recommendation by the agency’s Advisory Committee on Immunization Practices. Vaccinations …

Read More »

CDC Advisors Recommend Pfizer Vaccine For Kids 5-11

NPR reports: Children ages 5 through 11 years may soon be able to get a low-dose COVID-19 vaccine made by Pfizer-BioNTech. Advisors to the Centers for Disease Control and Prevention voted unanimously to recommend the shots Tuesday for the approximately 28 million children in this age group. If the recommendations are endorsed by CDC director Dr. Rochelle Walensky, as expected, …

Read More »

FDA Approves Low Dose Pfizer Vax For Kids 5-11

CNBC reports: The Food and Drug Administration on Friday authorized the use of Pfizer and BioNTech’s Covid-19 vaccine for children ages 5 to 11, a move that will make the shots available to 28 million kids in the U.S. The Centers for Disease Control and Prevention must sign off before shots can be distributed. It’s scheduled an advisory committee meeting …

Read More »

CDC Approves Fourth Shot For Immuno-Compromised

Axios reports: The Centers for Disease Control and Prevention said in updated guidelines Tuesday that some immuno compromised people who have received either Pfizer or Moderna’s COVID-19 vaccines will be able to get a fourth shot. People over 18 who are “moderately to severely immuno compromised” and have received three doses of an mRNA vaccine may get a fourth shot …

Read More »

FDA Panel Okays Pfizer Vax For Children Ages 5-11

The New York Times reports: A key advisory committee to the Food and Drug Administration voted overwhelmingly to recommend the use of Pfizer-BioNTech’s coronavirus vaccine in 5- to 11-year-olds, bringing the vaccine a big step closer to about 28 million children. Shots could be offered as early as next week. The panel endorsed giving the age group one-third of the …

Read More »

STUDY: Pfizer Vaccine 91% Effective In Kids Ages 5-11

ABC News reports: Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group. The shots could begin in early November — with the first children in line fully protected by Christmas — if regulators …

Read More »

Pfizer CEO: Trial Shows Booster Restores Full Protection

The Hill reports: Pfizer and BioNTech announced on Thursday that a booster shot of their coronavirus vaccine restores full protection against COVID-19. The companies said that a late-stage clinical trial found that the booster was 95.6 percent effective against symptomatic COVID-19. The efficacy results are the first from any randomized, controlled trial of a COVID-19 booster, they said. “These results …

Read More »

FDA To Allow “Mix And Match” For Booster Shots

The New York Times reports: The Food and Drug Administration is planning to allow Americans to receive a different Covid-19 vaccine as a booster than the one they initially received, a move that could reduce the appeal of the Johnson & Johnson vaccine and provide flexibility to doctors and other vaccinators. The government would not recommend one shot over another, …

Read More »

STUDY: Pfizer Vax Protection Weakens Faster In Men

The Washington Post reports: Women were found to generally have higher protection against the coronavirus than men after receiving a second shot of the Pfizer-BioNTech vaccine, according to a study released Wednesday — although immunity in both sexes tended to weaken within months after full vaccination. The study, published in the New England Journal of Medicine, also suggested that people …

Read More »

STUDY: Six Months After Second Dose Pfizer Vaccine Is 90% Effective In Preventing Hospitalization And Death

The Washington Post reports: The Pfizer-BioNTech coronavirus vaccine continues to be 90 percent effective in protecting against hospitalization and death from covid-19 up to six months after the second dose, even in the face of the widespread delta variant, a major study has found. The study was based on research from Pfizer and the Kaiser Permanente Southern California health system …

Read More »

CDC: No Unusual Side Effects From Vaccine Boosters

Bloomberg News reports: People who got Covid-19 vaccine boosters after the shots were cleared for people with weakened immune systems had mostly mild to moderate reactions, according to the U.S. Centers for Disease Control and Prevention. Some 22,191 booster recipients registered with a federal monitoring system starting Aug. 12, when the doses were first authorized on an emergency basis by …

Read More »

Pfizer Asks FDA To Approve Vax For Children 5 To 11

NBC News reports: Pfizer-BioNTech requested Tuesday that the Food and Drug Administration clear its Covid-19 vaccine for use in children ages 5 to 11. The FDA is expected to take at least several weeks to analyze data collected in a trial that included more than 2,000 children before it would grant emergency use authorization. While the Pfizer vaccine has been …

Read More »

Pfizer Begins Study Of Oral COVID-19 Preventive

Reuters reports: Pfizer Inc said on Monday it has started a mid-to-late-stage study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus.  The company and its rivals, including Merck & Co Inc and Roche Holding AG, have been racing to develop the first antiviral pill for COVID-19. Pfizer …

Read More »